Showing results (221-230 of 274) with videos related to
Sort By:
Pageof 28
Leukemia|October 10, 1998
Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemiaM H Woo, L J Hak, M C Storm, et al.Medical and Pediatric Oncology|January 1, 1988
High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study XM Abromowitch, J Ochs, C H Pui, et al.The Journal of Clinical Investigation|November 1, 1994
Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemiaT W Synold, M V Relling, J M Boyett, et al.Blood|February 25, 1999
Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulationV M Belkov, E Y Krynetski, J D Schuetz, et al.Bone|June 24, 2000
Sib pair linkage and association studies between bone mineral density and the interleukin-6 gene locusI Takacs, D L Koller, M Peacock, et al.Clinical Pharmacology and Therapeutics|August 8, 2008
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemiaG Stocco, M H Cheok, K R Crews, et al.Leukemia|November 13, 2010
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivityS-H Chen, W Yang, Y Fan, et al.Leukemia|August 11, 1998
Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemiaJ E Rubnitz, M V Relling, P L Harrison, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Unexpectedly severe toxicity from intensive early treatment of childhood lymphoblastic leukemiaG K Rivera, W E Evans, D K Kalwinsky, et al.Pageof 28